PPDTM CorEvitasTM Vitiligo Drug Safety and Effectiveness Registry for Adults & Adolescents
Part of paid clinical trials in Waltham, Massachusetts.
- Sponsor
- CorEvitas
- Study ID
- NCT07659418
- Status
- Enrolling By Invitation
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 12 Years - N/A
- Healthy Volunteers
- Accepted
Study Details
The design is a prospective, observational (non-interventional) registry for adolescent and adult subjects with NSV under the care of a dermatology provider.
Key Dates
- Start date
- Jun 30, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2099
- Completion
- Dec 31, 2099
Study Design
- Enrollment
- 2,500 participants (estimated)
Primary Outcome Measure
Vitiligo Epidemiology and presentation [ Time Frame: Every 6 months for 10 years] ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| CorEvitas, LLC | Waltham | Massachusetts | 02451 | - |
Find similar trials in Waltham, MA
By research site
Related Studies
- A Study of LY4005130 in Adult Participants With Non-Segmental VitiligoPHASE2 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- The Gut and Skin Microbiome in Vitiligo Disease ProgressionRecruiting · Northwestern University · Chicago, Illinois